Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FQWC2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,793
Award facts
- Contract value 100% obligated
- $24,793.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of JAKAFI 5 mg tablets (60-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The ultimate completion date is November 19, 2025, with performance occurring at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion program established to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The parent contract, designated SPE2DR and awarded November 13, 2025, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy, with a 30-month base period and three 30-month option periods extending through December 31, 2036. The company's established performance on numerous prior delivery orders across diverse pharmaceutical categories, including specialty drugs and biologics, demonstrates its capability to fulfill the specialized requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQWC2?
SPE2DR26FQWC2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQWC2 worth?
The government has obligated $24,793 on SPE2DR26FQWC2.
Is contract SPE2DR26FQWC2 an order under another contract?
Yes. SPE2DR26FQWC2 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWC2 competed?
The extent of competition for SPE2DR26FQWC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award